{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Distinguishing minimally invasive carcinoma and adenocarcinoma in situ from invasive adenocarcinoma with intratumoral and peri-tumoral textural features", "item": "https://www.patentleaderboard.com/patent/11464473"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Distinguishing minimally invasive carcinoma and adenocarcinoma in situ from invasive adenocarcinoma with intratumoral and peri-tumoral textural features

Distinguishing minimally invasive carcinoma and adenocarcinoma in situ from invasive adenocarcinoma with intratumoral and peri-tumoral textural features

US Patent 11464473 · Granted Oct 11, 2022

Estimated economic value: $727,214,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phenotyping tumor infiltrating lymphocytes on hematoxylin and eosin (H and E) st2025
Batch effect mitigation in digitized images2025
Tumor characterization and outcome prediction through quantitative measurements 2025
Fully automated assessment of coronary vulnerable plaque in coronary CT images u2025
Quality control for digital pathology slides2025
Intra-perinodular textural transition (ipris): a three dimenisonal (3D) descript2025
Combination of features from biopsies and scans to predict prognosis in SCLC2024
Computational features of tumor-infiltrating lymphocyte (TIL) architecture2024
Distinguishing colon cancer stages based on computationally derived morphologica2024
Population-specific prediction of prostate cancer recurrence based on stromal mo2024
Predicting neo-adjuvant chemotherapy response from pre-treatment breast magnetic2024
Predicting overall survival in early stage lung cancer with feature driven local2024